The forecast for the import of insulin not in dosage forms to Canada shows a steadily increasing trend from 2024 to 2028, with values growing from 11.04 to 11.14 thousand kilograms. This consistent rise reflects a stable annual growth rate. However, without data from 2023 and before, the percentage change for year-on-year variations cannot be calculated, nor the compound annual growth rate (CAGR) for a five-year period.
Future trends to watch include:
- Advancements in diabetes treatment, potentially affecting demand.
- Global trade policies influencing import volumes.
- Technological improvements in insulin production.
